Literature DB >> 16689667

Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.

D Michele Basso1, Lesley C Fisher, Aileen J Anderson, Lyn B Jakeman, Dana M McTigue, Phillip G Popovich.   

Abstract

Genetically engineered mice are used extensively to examine molecular responses to spinal cord injury (SCI). Inherent strain differences may confound behavioral outcomes; therefore, behavioral characterization of several strains after SCI is warranted. The Basso, Beattie, Bresnahan Locomotor Rating Scale (BBB) for rats has been widely used for SCI mice, but may not accurately reflect their unique recovery pattern. This study's purpose was to develop a valid locomotor rating scale for mice and to identify strain differences in locomotor recovery after SCI. We examined C57BL/6, C57BL/10, B10.PL, BALB/c, and C57BL/6x129S6 F1 strains for 42 days after mild, moderate, and severe contusive SCI or transection of the mid thoracic spinal cord. Contusions were created using the Ohio State University electromagnetic SCI device which is a displacement-driven model, and the Infinite Horizon device, which is a force-driven model. Attributes and rankings for the Basso Mouse Scale for Locomotion (BMS) were determined from frequency analyses of seven locomotor categories. Mouse recovery differed from rats for coordination, paw position and trunk instability. Disagreement occurred across six expert raters using BBB (p < 0.05) but not BMS to assess the same mice. BMS detected significant differences in locomotor outcomes between severe contusion and transection (p < 0.05) and SCI severity gradations resulting from displacement variations of only 0.1 mm (p < 0.05). BMS demonstrated significant face, predictive and concurrent validity. Novice BMS raters with training scored within 0.5 points of experts and demonstrated high reliability (0.92-0.99). The BMS is a sensitive, valid and reliable locomotor measure in SCI mice. BMS revealed significantly higher recovery in C57BL/10, B10.PL and F1 than the C57BL/6 and BALB/c strains after moderate SCI (p < 0.05). The differing behavioral response to SCI suggests inherent genetic factors significantly impact locomotor recovery and must be considered in studies with inbred or genetically engineered mouse strains.

Entities:  

Mesh:

Year:  2006        PMID: 16689667     DOI: 10.1089/neu.2006.23.635

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  568 in total

1.  Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.

Authors:  Jee Y Lee; So R Kang; Tae Y Yune
Journal:  J Neurotrauma       Date:  2015-03-06       Impact factor: 5.269

2.  Recovery from chronic spinal cord contusion after Nogo receptor intervention.

Authors:  Xingxing Wang; Philip Duffy; Aaron W McGee; Omar Hasan; Grahame Gould; Nathan Tu; Noam Y Harel; Yiyun Huang; Richard E Carson; David Weinzimmer; Jim Ropchan; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

3.  Attenuating the endoplasmic reticulum stress response improves functional recovery after spinal cord injury.

Authors:  Sujata Saraswat Ohri; Melissa A Maddie; Yongmei Zhao; Mengsheng S Qiu; Michal Hetman; Scott R Whittemore
Journal:  Glia       Date:  2011-06-02       Impact factor: 7.452

4.  Deletion of the pro-apoptotic endoplasmic reticulum stress response effector CHOP does not result in improved locomotor function after severe contusive spinal cord injury.

Authors:  Sujata Saraswat Ohri; Melissa A Maddie; Yiping Zhang; Christopher B Shields; Michal Hetman; Scott R Whittemore
Journal:  J Neurotrauma       Date:  2011-11-21       Impact factor: 5.269

5.  Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

Authors:  Bo Chen; Yi Li; Bin Yu; Zicong Zhang; Benedikt Brommer; Philip Raymond Williams; Yuanyuan Liu; Shane Vincent Hegarty; Songlin Zhou; Junjie Zhu; Hong Guo; Yi Lu; Yiming Zhang; Xiaosong Gu; Zhigang He
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

6.  Neuronal Ablation of IKK2 Decreases Lesion Size and Improves Functional Outcome after Spinal Cord Injury in Mice.

Authors:  Ditte Gry Ellman; Hans Gram Novrup; Louise Helskov Jørgensen; Minna Christiansen Lund; Minna Yli-Karjanmaa; Pernille Marie Madsen; Jonas Heinrich Vienhues; Safinaz Dursun; John R Bethea; Karin Lykke-Hartmann; Roberta Brambilla; Kate Lykke Lambertsen
Journal:  JSM Neurosurg Spine       Date:  2017-08-10

7.  Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity.

Authors:  Daisuke Umebayashi; Atsushi Natsume; Hideyuki Takeuchi; Masahito Hara; Yusuke Nishimura; Ryuichi Fukuyama; Naoyuki Sumiyoshi; Toshihiko Wakabayashi
Journal:  J Neurotrauma       Date:  2014-09-23       Impact factor: 5.269

8.  Diffusion tensor imaging as a predictor of locomotor function after experimental spinal cord injury and recovery.

Authors:  Brian J Kelley; Noam Y Harel; Chang-Yeon Kim; Xenophon Papademetris; Daniel Coman; Xingxing Wang; Omar Hasan; Adam Kaufman; Ronen Globinsky; Lawrence H Staib; William B J Cafferty; Fahmeed Hyder; Stephen M Strittmatter
Journal:  J Neurotrauma       Date:  2014-07-08       Impact factor: 5.269

9.  Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Authors:  Erik Mire; Nicole Thomasset; Lyn B Jakeman; Geneviève Rougon
Journal:  Mol Cell Neurosci       Date:  2007-10-03       Impact factor: 4.314

10.  Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury.

Authors:  Ji-Dong Guo; Li Li; Ya-Min Shi; Hua-Dong Wang; Yan-Li Yuan; Xiu-Xiu Shi; Shu-Xun Hou
Journal:  Mol Cell Biochem       Date:  2014-02-14       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.